RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Nouscom

Nouscom

Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.

Health and bio
Latest funding

$135.04M Series B+ ·

Led by M Ventures · Source: manilatimes.net

Total raised: $267.56M across 4 sourced rounds

All 4 rounds ↓
Website: nouscom.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Genetics, Health Care, Therapeutics.
Stage: Series B+.
Based in: Basel, Switzerland.
Founded: 2015.
Total raised: $267.56M in 4 sourced rounds.
Last round: Oct 19, 2026 · 4 days ago.
Headcount: 11–50 employees.
Domain age: 12 years.
On Recent Funding since: Oct 19, 2026.
About Nouscom

Nouscom is a company based in Basel, Switzerland, founded in 2015. Recent Funding lists it under Health and bio. It raised $135.04M in a Series B+ round in October 2026, led by M Ventures, according to manilatimes.net. Recent Funding has 4 sourced rounds on record for it, totaling $267.56M, the first in May 2016. Investors on record include 5AM Ventures, Abingworth, Andera Partners, Angelini Industries and 11 others. It was founded by Cinzia Traboni, Elisa Scarduelli and Riccardo Cortese.

TIMELINE · MONEY RAISED

Nouscom | 567 days from website to first raise on record

Raised $268M in 4 sourced rounds·1 signal before the first raise
$67M$134M$201M$268MNOVJUNJAN 2018AUGMAROCTMAYDEC$268M||WEBSITE CREATED · OCT 28, 2014$13.58M Series A · May 17, 2016$13.58M A · MAY '16$46.94M Series B+ · Jun 11, 2017$46.94M B+ · JUN '17$72M Series B+ · Nov 14, 2023$72M B+ · NOV '23$135.04M Series B+ · Oct 19, 2026$135.04M B+ · OCT '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

  1. Series B+ · $135.04M
    MM Ventures (lead), RRevelation Partners (lead), CCDP Venture Capital, EEQT Life Sciences, EEuropean Investment Bank Group, IIndaco Venture Partners, NNeva SGR, PPanakes Partners, VVersant Ventures, XXGEN Venture
    Source: manilatimes.net
  2. Series B+ · $72M
    AAndera Partners (lead), BBpifrance (lead), MM Ventures (lead), 55AM Ventures, EEQT Life Sciences, IIndaco Venture Partners, PPanakes Partners, RRevelation Partners, VVersant Ventures, XXGEN Venture
    Source: finance.yahoo.com
  3. Series B+ · $46.94M
    AAbingworth (lead), 55AM Ventures, LLSP BioVentures, VVersant Ventures
    Source: european-biotechnology.com
  4. Series A · $13.58M
    EEQT Life Sciences (lead), VVersant Ventures
    Source: finsmes.com
  5. Website created

Founders and team

Investors

Similar Health and bio companies

Other companies backed by M Ventures

M Ventures portfolio →

Questions and sources

Nouscom: questions and answers

How much has Nouscom raised?
Nouscom has raised $267.56M across 4 sourced rounds on record. The latest is $135.04M (Series B+), announced October 19, 2026.
Who invested in Nouscom?
Investors on record for Nouscom: 5AM Ventures, Abingworth, Andera Partners, Angelini Industries, Angelini Ventures, Bpifrance, CDP Venture Capital, EQT Life Sciences and 9 others. M Ventures led its latest sourced round.
Who founded Nouscom?
Nouscom was founded by Cinzia Traboni, Elisa Scarduelli and Riccardo Cortese.
Where is Nouscom based?
Nouscom is based in Basel, Switzerland and was founded in 2015.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nouscom (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy